Acute myocardial infarction is now considered more treatable than ever. However, despite optimized reperfusion, modern pharmacotherapies and improved care systems, one risk remains that is underestimated in many clinical procedures: the development of new heart failure after surviving an infarction. A recent analysis by a large US healthcare system shows that post-infarction heart failure occurs more frequently than a new myocardial infarction – and significantly affects the prognosis of those affected.
You May Also Like
- From Risk Identification to Anti-Inflammatory Intervention
Inflammation as a Treatment Goal in Its Own Right
- Psoriasis Research: What's in the Pipeline?
Highly selective oral TYK inhibitors in Phase III
- Cardiometabolism
Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon
- Pediatric Retinoblastoma
The Tumor Microenvironment and Modern Eye-Sparing Therapies
- Adherence and management in asthma and COPD
Better to listen to the pharmacist
- Focus Update 2026
Echocardiography in Cardio-Oncology
- Physical activity with IBD
Sport is not murder, but it doesn’t help either
- White and Black Skin Cancer